Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients
Journal of Medical Virology · 2024
DOI: 10.1002/jmv.70099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von André N A Gonçalves und 24 weiteren Autor:innen. Beteiligte Einrichtung: Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Oxford, UK. Hauptthemen laut MEDLINE: Yellow Fever. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: This study was supported by the Bill & Melinda Gates Foundation, FAPESP, HCFMUSP, and USP..
Abstract (Originalsprache)
In the 2018 yellow fever (YF) outbreak in Brazil, we generated new transcriptomic data and combined it with clinical and immunological data to decode the pathogenesis of YF. Analyzing 79 patients, we found distinct gene expression patterns between acute YF, other viral infections, and the milder YF‐17D vaccine infection. We identified a critical role for low‐density, immature neutrophils in severe outcomes, marked by the downregulation of genes essential for neutrophil migration and maturation, such as PADI4, CSF3R, and ICAM1, in deceased patients. Our study also revealed complex interactions among inflammation‐related genes, including increased CXCL10 and IL1R2 expression and decreased IL‐1b expression in the acute phase. The diminished expression of HLA class II genes indicates impaired antigen presentation. These findings highlight the delicate balance of immune responses in YF pathogenesis and lay the groundwork for future therapeutic and diagnostic advancements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oxford Vaccine Group, NIHR Oxford Biomedical Research Centre, Oxford, UK.
- Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
- Medical Investigation Laboratory 60 (LIM-60), Medical School, University of São Paulo, São Paulo, Brazil.
- Clinicas Hospital, Medical School, University of São Paulo, São Paulo, Brazil.
- Institute of Infectology "Emilio Ribas", São Paulo, Brazil.
- Department of Infectious and Parasitic Diseases, School of Medicine, University of São Paulo, São Paulo, Brazil.
ORCID-Profile: Otavio Cabral-Marques, Helder I Nakaya
Förderung
- This study was supported by the Bill & Melinda Gates Foundation, FAPESP, HCFMUSP, and USP.
Zitieren
APA
Gonçalves, A. N. A., Costa, P. R., Thomazella, M. V., Correia, C. A., Marmorato, M. P., Dias, J. Z. C., Silveira, C. G. T., Maestri, A., Cerqueira, N. B., Moreira, C. H. V., Buccheri, R., Félix, A. C., Martins, F. M., Maso, V. E., Ferreira, F. M., Araújo, J. D. A., Vasconcelos, A. P., Gonzalez-Dias, P., Pelletier, A. N., …, & Nakaya, H. I. (2024). Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients. Journal of Medical Virology. https://doi.org/10.1002/jmv.70099
Vancouver
Gonçalves ANA, Costa PR, Thomazella MV, Correia CA, Marmorato MP, Dias JZC, et al. Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients. Journal of Medical Virology. 2024. doi:10.1002/jmv.70099
BibTeX
@article{Gonalves2024,
author = {Gonçalves, André N A and Costa, Priscilla R and Thomazella, Mateus V and Correia, Carolina A and Marmorato, Mariana P and Dias, Juliana Z C and Silveira, Cassia G T and Maestri, Alvino and Cerqueira, Natalia B and Moreira, Carlos H V and Buccheri, Renata and Félix, Alvina C and Martins, Felipe M and Maso, Vanessa E and Ferreira, Frederico M and Araújo, José D A and Vasconcelos, Amanda P and Gonzalez-Dias, Patrícia and Pelletier, Adam-Nicolas and Sékaly, Rafick-Pierre and Cabral-Marques, Otavio and Coelho-Dos-Reis, Jordana G A and Ferreira, Daniela M and Kallas, Esper G and Nakaya, Helder I},
title = {Systems Immunology Approaches to Understanding Immune Responses in Acute Infection of Yellow Fever Patients},
journal = {Journal of Medical Virology},
year = {2024},
doi = {10.1002/jmv.70099}
}
EUVIMED